Analgosedierung in der Intensivmedizin

Die Analgosedierung intensivmedizinischer Patienten ist eine im klinischen Alltag regelhaft auftretende, komplexe Aufgabe. Es gilt, dem individuellen Patienten das für ihn am besten geeignete Medikament so zu verabreichen, dass eine effektive Wirkung erreicht und unerwünschte Nebenwirkungen minimiert werden. Dieser Artikel soll eine Übersicht über die Ziele der kontinuierlichen Sedierung sowie die aktuell verfügbaren, gängigen Pharmaka vermitteln.

Kernaussagen

• Ein der individuellen Situation des Patienten angemessenes Sedierungsregime kann maßgeblich zum Genesungsprozess des Patienten beitragen.

• Das regelmäßige Management der Sedierungstiefe anhand valider Scores stellt einen Qualitätsindikator der intensivmedizinischen Therapie dar.

• Zum Erreichen einer adäquaten Sedierung steht eine Vielzahl an Pharmaka zur Verfügung.

• Bei der Auswahl der Pharmaka sollte sowohl auf einen ausreichenden sedierenden als auch analgetischen Effekt geachtet werden.

• Spezielle Patientengruppen erfordern ein angepasstes Sedierungsregime.

Schlüsselwörter

Sedierung - Intensivmedizin - Analgesie - Delir

Publication History

Article published online:
26 August 2024

• Literatur

• 1 Puntillo KA, Arai S, Cohen NH. et al. Symptoms experienced by intensive care unit patients at high risk of dying. Crit Care Med 2010; 38: 2155-2160 DOI: 10.1097/CCM.0b013e3181f267ee. (PMID: 20711069)
• 2 Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin e.V. (DGAI), Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin e.V. (DIVI). S3-Leitlinie Analgesie, Sedierung und Delirmanagement in der Intensivmedizin (DAS-Leitlinie). AWMF-Registernummer: 001/012. (federführend) Accessed June 18, 2024 at: https://register.awmf.org/de/leitlinien/detail/001–012
• 3 Kumpf O, Assenheimer M, Bloos F. et al. Intensivmedizinische Qualitätsindikatoren für Deutschland. Anästh Intensivmed 2023; 64: 333-354 DOI: 10.19224/ai2023.333.
• 4 Jakob SM, Lubszky S, Friolet R. et al. Sedation and weaning from mechanical ventilation: effects of process optimization outside a clinical trial. J Crit Care 2007; 22: 219-228 DOI: 10.1016/J.JCRC.2007.01.001. (PMID: 17869972)
• 5 Arabi Y, Haddad S, Hawes R. et al. Changing sedation practices in the intensive care unit--protocol implementation, multifaceted multidisciplinary approach and teamwork. Middle East J Anaesthesiol 2007; 19: 429-447 (PMID: 17684883)
• 6 Girard TD, Kress JP, Fuchs BD. et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008; 371: 126-134 DOI: 10.1016/S0140-6736(08)60105-1. (PMID: 18191684)
• 7 Shehabi Y, Bellomo R, Kadiman S. et al. Sedation intensity in the first 48 hours of mechanical ventilation and 180-day mortality: a multinational prospective longitudinal cohort study. Crit Care Med 2018; 46: 850-859 DOI: 10.1097/CCM.0000000000003071. (PMID: 29498938)
• 8 Balzer F, Weiß B, Kumpf O. et al. Early deep sedation is associated with decreased in-hospital and two-year follow-up survival. Crit Care 2015; 19: 197 DOI: 10.1186/s13054-015-0929-2. (PMID: 25928417)
• 9 Pandharipande P, Cotton BA, Shintani A. et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 2008; 65: 34-41 DOI: 10.1097/TA.0B013E31814B2C4D. (PMID: 18580517)
• 10 Pandharipande PP, Pun BT, Herr DL. et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298: 2644-2653 DOI: 10.1001/JAMA.298.22.2644.
• 11 Pisani MA, Murphy TE, Araujo KLB. et al. Benzodiazepine and opioid use and the duration of ICU delirium in an older population. Crit Care Med 2009; 37: 177 DOI: 10.1097/CCM.0B013E318192FCF9. (PMID: 19050611)
• 12 Ely EW, Truman B, Shintani A. et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003; 289: 2983-2991 DOI: 10.1001/jama.289.22.2983. (PMID: 12799407)
• 13 Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999; 27: 1325-1329 DOI: 10.1097/00003246-199907000-00022. (PMID: 10446827)
• 14 Ramsay MAE, Savege TM, Simpson BRJ. et al. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2: 656 DOI: 10.1136/BMJ.2.5920.656.
• 15 Chanques G, Viel E, Constantin JM. et al. The measurement of pain in intensive care unit: comparison of 5 self-report intensity scales. Pain 2010; 151: 711-721 DOI: 10.1016/J.PAIN.2010.08.039. (PMID: 20843604)
• 16 Payen JF, Bru O, Bosson JL. et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 2001; 29: 2258-2263 DOI: 10.1097/00003246-200112000-00004. (PMID: 11801819)
• 17 Chanques G, Payen JF, Mercier G. et al. Assessing pain in non-intubated critically ill patients unable to self report: an adaptation of the Behavioral Pain Scale. Intensive Care Med 2009; 35: 2060-2067 DOI: 10.1007/S00134-009-1590-5. (PMID: 19697008)
• 18 Lagger V, Mahrer Imhof R, Imhof L. Schmerzmanagement bei Patienten mit kognitiven Beeinträchtigungen: ein Forschungsanwendungsprojekt. Pflege 2008; 21: 149-156 DOI: 10.1024/1012-5302.21.3.149. (PMID: 18622989)
• 19 Luetz A, Balzer F, Radtke FM. et al. Delirium, sedation and analgesia in the intensive care unit: a multinational, two-part survey among intensivists. PLoS One 2014; 9: 110935 DOI: 10.1371/journal.pone.0110935. (PMID: 25398099)
• 20 De Deyne C, Struys M, Decruyenaere J. et al. Use of continuous bispectral EEG monitoring to assess depth of sedation in ICU patients. Intensive Care Med 1998; 24: 1294-1298 DOI: 10.1007/S001340050765. (PMID: 9885883)
• 21 Swisher CB, Shah D, Sinha SR. et al. Baseline EEG pattern on continuous ICU EEG monitoring and incidence of seizures. J Clin Neurophysiol 2015; 32: 147-151 DOI: 10.1097/WNP.0000000000000157. (PMID: 25437330)
• 22 Deutsche Gesellschaft für Neurologie e.V. (DGN). S1-Leitlinie Delir und Verwirrtheitszustände inklusive Alkoholentzugsdelir. (federführend) Accessed June 18, 2024 at: https://register.awmf.org/de/leitlinien/detail/030–006
• 23 Fragen RJ. Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units. Clin Ther 1997; 19: 405-419 DOI: 10.1016/S0149-2918(97)80126-9. (PMID: 9220206)
• 24 Devlin JW, Skrobik Y, Gélinas C. et al. Executive summary: clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018; 46: 1532-1548 DOI: 10.1097/CCM.0000000000003259. (PMID: 30113371)
• 25 Tonner P, Hein L. Phamakotherapie in der Anästhesie und Intensivmedizin. Berlin, Heidelberg: Springer; 2011
• 26 Prause A, Wappler F, Scholz J. et al. Respiratory depression under long-term sedation with sufentanil, midazolam and clonidine has no clinical significance. Intensive Care Med 2000; 26: 1454-1461 DOI: 10.1007/s001340000637. (PMID: 11126256)
• 27 Ethuin F, Boudaoud S, Leblanc I. et al. Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients. Intensive Care Med 2003; 29: 1916-1920 DOI: 10.1007/s00134-003-1920-y. (PMID: 12923616)
• 28 Pöpping DM, Elia N, Van Aken HK. et al. Impact of epidural analgesia on mortality and morbidity after surgery: systematic review and meta-analysis of randomized controlled trials. Ann Surg 2014; 259: 1056-1067 DOI: 10.1097/SLA.0000000000000237. (PMID: 24096762)
• 29 Pöpping DM, Elia N, Marret E. et al. Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: a meta-analysis. Arch Surg 2008; 143: 990-999 DOI: 10.1001/ARCHSURG.143.10.990. (PMID: 18936379)
• 30 Guay J, Nishimori M, Kopp SL. Epidural local anesthetics versus opioid-based analgesic regimens for postoperative gastrointestinal paralysis, vomiting, and pain after abdominal surgery: a Cochrane review. Anesth Analg 2016; 123: 1591-1602 DOI: 10.1213/ANE.0000000000001628. (PMID: 27870743)
• 31 Slinchenkova K, Lee K, Choudhury S. et al. A review of the paravertebral block: benefits and complications. Curr Pain Headache Rep 2023; 27: 203-208 DOI: 10.1007/S11916-023-01118-1. (PMID: 37294514)
• 32 Yeung JHY, Gates S, Naidu BV. et al. Paravertebral block versus thoracic epidural for patients undergoing thoracotomy. Cochrane Database Syst Rev 2016; (02) CD009121 DOI: 10.1002/14651858.CD009121.pub2.
• 33 Town CJ, Johnson J, Van Zundert A. et al. Exploring the role of regional anesthesia in the treatment of the burn-injured patient: a narrative review of current literature. Clin J Pain 2019; 35: 368-374 DOI: 10.1097/AJP.0000000000000680. (PMID: 30540588)
• 34 Wappler F. Das Propofol-Infusionssyndrom: Klinik, Pathophysiologie und Therapie einer seltenen Komplikation. Dtsch Arztebl 2006; 103: 705-710
• 35 Bernard JM, Kick O, Bonnet F. Comparison of intravenous and epidural clonidine for postoperative patient-controlled analgesia. Anesth Analg 1995; 81: 706-712 DOI: 10.1097/00000539-199510000-00009. (PMID: 7573998)
• 36 Shehabi Y, Serpa Neto A, Bellomo R. et al. Dexmedetomidine and propofol sedation in critically Ill patients and dose-associated 90-day mortality: a secondary cohort analysis of a randomized controlled trial (SPICE III). Am J Respir Crit Care Med 2023; 207: 876-886 DOI: 10.1164/rccm.202206-1208OC.
• 37 Shehabi Y, Forbes AB, Arabi Y. et al. The SPICE III study protocol and analysis plan: a randomised trial of early goaldirected sedation compared with standard care in mechanically ventilated patients. Crit Care Resusc 2017; 19: 318-326 DOI: 10.1016/S1441-2772(23)00956-0.
• 38 Sackey P V, Martling C-R, Granath F. et al. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit Care Med 2004; 32: 2241-2246 DOI: 10.1097/01.ccm.0000145951.76082.77.
• 39 Krannich A, Leithner C, Engels M. et al. Isoflurane sedation on the ICU in cardiac arrest patients treated with targeted temperature management: an observational propensity-matched study. Crit Care Med 2017; 45: e384-e390 DOI: 10.1097/CCM.0000000000002185.
• 40 Schuster M, Richter H, Pecher S. et al. Positionspapier mit konkreten Handlungsempfehlungen* der DGAI und des BDA: Ökologische Nachhaltigkeit in der Anästhesiologie und Intensivmedizin. Anästh Intensivmed 2020; 61: 329-339 DOI: 10.19224/ai2020.329.
• 41 Riker RR, Shehabi Y, Bokesch PM. et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009; 301: 489-499 DOI: 10.1001/JAMA.2009.56. (PMID: 19188334)
• 42 Weiss B, Hilfrich D, Vorderwülbecke G. et al. Outcomes in critically Ill Patients sedated with intravenous lormetazepam or midazolam: a retrospective cohort study. J Clin Med 2021; 10: 4091 DOI: 10.3390/JCM10184091. (PMID: 34575204)
• 43 Pambianco DJ, Borkett KM, Riff DS. et al. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc 2016; 83: 984-992 DOI: 10.1016/J.GIE.2015.08.062. (PMID: 26363333)
• 44 Richter M. Analgesie und Sedierung bei Kindern. Intensivmedizin up2date 2022; 18: 345-361 DOI: 10.1055/A-1532-8926.
• 45 Brennan PG, Landry JK, Miles MVP. et al. Intravenous ketamine as an adjunct to procedural sedation during burn wound care and dressing changes. J Burn Care Res 2019; 40: 246-250 DOI: 10.1093/JBCR/IRY044.
• 46 Warncke T, Stubhaug A, Jorum E. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain 1997; 72: 99-106 DOI: 10.1016/S0304-3959(97)00006-7.
• 47 Asmussen S, Maybauer DM, Fraser JF. et al. A meta-analysis of analgesic and sedative effects of dexmedetomidine in burn patients. Burns 2013; 39: 625-631 DOI: 10.1016/j.burns.2013.01.008. (PMID: 23465796)